Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from AOTI, Inc. ( (GB:AOTI) ) is now available.
AOTI, Inc. announced that its Non-executive Chairman, Mr. Douglas Lefort, has purchased 31,094 common shares, increasing his total holding to 1,482,715 shares, which represents approximately 1.39% of the company’s issued share capital. This transaction, conducted on the London Stock Exchange, reflects a significant investment by a key company leader, potentially signaling confidence in the company’s strategic direction and future performance.
More about AOTI, Inc.
AOTI, Inc., founded in 2006 and based in Oceanside, California, US and Galway, Ireland, specializes in providing innovative solutions for severe and chronic wound care. The company’s flagship product, the patented non-invasive Topical Wound Oxygen (TWO2®) therapy, has been shown to significantly reduce the recurrence of Diabetic Foot Ulcers and associated hospitalizations and amputations. This therapy is approved by regulatory bodies in the US, Europe, UK, Canada, China, Australia, and Saudi Arabia.
Average Trading Volume: 43,193
Technical Sentiment Signal: Strong Sell
Current Market Cap: £85.09M
For an in-depth examination of AOTI stock, go to TipRanks’ Stock Analysis page.